G. Joos (Ghent, Belgium), P. J. Sterk (Amsterdam, The Netherlands)
Baseline airway inflammation may be a determinant of ozone response in asthmatic patients M.L. Bartoli, B. Vagaggini, L. Malagrinò, E. Bacci, S. Cianchetti, F. Dente, F. Costa, P. Paggiaro (Pisa, Italy)
| |
Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial A. Scherr, A. Jochmann, D. Miedinger, S. Maier, S. Schafroth Török, P. Chhajed, M. Tamm, J. Leuppi (Basel, Switzerland)
| |
Electromyography of the parasternal intercostal muscles in bronchial hyperresponsiveness testing V. MacBean, A. Ali, C. Wood, T. Fleming, A. Greenough, G.F. Rafferty, J. Moxham (London, United Kingdom)
| |
Clara cell protein (CC16) in serum and urine after exercise challenge E. Tufvesson, H. Svensson, L. Bjermer (Lund, Sweden)
| |
Alterations in static lung volumes during methacholine challenge (MCH) tests, assessed by whole-body plethysmography using the aerosol provocation system (APS) R. Kraemer, G. Giger, T. Sigrist, M. Frey (Berne, Switzerland)
| |
Bronchial hyperresponsiveness using mannitol in morbid obesity before and after bariatric surgery E. Arismendi, E. Rivas, Y. Torralba, F. Burgos, J. Roca, J. Vidal, R. Rodriguez-Roisin (Palma de Mallorca, Spain)
| |
Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter R. Kraemer, G. Giger, T. Sigrist, M. Frey (Berne, Switzerland)
| |
Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids W. Anderson, B. Lipworth (Dundee, United Kingdom)
| |